Houston-based Verdant Specialty Solutions has announced its first acquisitions since being sold by Solvay to OpenGate Capital in April and renamed, in the form of DeForest Enterprises and ParaFlow Energy Solutions from Chemical Services Group of Boca Raton, Florida. Terms were not disclosed.
DuPont and the companies that used to be part of it, Chemours and Corteva, have reached a settlement with the Delaware Department of Justice. Under this, they are held responsible for decades of damage done to Delaware’s environment by per- and polyfluoroalkyl substances (PFASs).
Flush with funds from its IPO, Indian speciality chemicals manufacturer Rossari is to make its second acquisition of in as many months.
UK distributors hit by driver shortage The Chemical Business Association (CBA), which represents chemical distributors and logistics services providers in the UK, has again highlighted the chronic shortage of HGV drivers since Brexit.
Due to the ongoing COVID-19 pandemic and continued uncertainties about international travel, Mack-Brooks Exhibitions has announced the postponement of Chemspec Europe 2021, which was scheduled to take place at Messe Frankfurt on 29-30 September 2021.
Emily Newton, editor of Revolutionized Magazine, looks at how chemical processing plants can improve their performance by anticipating rather than reacting to maintenance issues
Two pharmaceutical CDMOs, AMRI in the US and UK-based Arcinova, have almost simultaneously announced full corporate rebranding exercises.
Draslovka, a multi-family-owned Czech speciality chemicals firm, has agreed to acquire the sodium cyanide business of Sasol for $101.7 million and will invest a further $50 million to modernise and expand the site at Sasolburg and bring it up to Draslovska’s environmental standards.
New York-based private investment New Mountain Capital has acquired Ascensus Specialties from its previous majority owner, Wind Point Partners. Terms were not disclosed.
Current Issue
Houston-based Verdant Specialty Solutions has announced its first acquisitions since being sold by Solvay t
DuPont and the companies that used to be part of it, Chemours and Corteva, have reached a settlement with t
Flush with funds from its IPO, Indian speciality chemicals manufacturer Rossari is to make its second acqui
UK distributors hit by driver shortage The Chemical Business Association (CBA), which represents chemical d
Most Popular
The European Chemicals Agency (ECHA) and the European Commission have announced plans to help EU member states and industry to address disinfectant shortages caused by the Covid-19 pandemic.
Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the current crisis*
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general.
In a pre-close trading update for the financial year ended 31 March 2021, Johnson Matthey (JM) CEO Robert MacLeod revealed that: “We have commenced a strategic review of Health, as we continue to focus resources to maximise value for our shareholders”.
Full results will be announced on 27 May but it is known that Health, which offers API custom manufacturing services, controlled substances, catalysts and generics, generated sales of £223 million, about 5% of the total sale. The division’s full-year operating performance is expected to be above the prior year.
